MoneyWorks4Me

Orchid Pharma - Quaterly Results

11 Nov 2024 Evaluate
The September 2024 quarter revenue stood at Rs. 2226.99 millions, up 12.05% as compared to Rs. 1987.55 millions during the corresponding quarter last year.A comparatively good net profit growth of 26.60% to Rs. 256.27 millions was reported for the quarter ended September 2024 compared to Rs. 202.42 millions of previous same quarter.Operating profit surged to 375.48 millions from the corresponding previous quarter of 318.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2226.99 1987.55 12.05 4671.05 3816.75 22.38 8193.68 6658.98 23.05
Other Income 79.63 81.82 -2.68 157.35 100.68 56.29 303.89 194.30 56.40
PBIDT 375.48 318.81 17.78 785.68 559.09 40.53 1410.70 1030.49 36.90
Interest 32.96 37.98 -13.22 67.69 93.43 -27.55 163.28 322.26 -49.33
PBDT 342.52 280.83 21.97 717.99 465.66 54.19 1247.42 1100.33 13.37
Depreciation 86.25 78.41 10.00 170.69 155.49 9.78 332.19 547.87 -39.37
PBT 256.27 202.42 26.60 547.30 310.17 76.45 915.23 552.46 65.66
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
PAT 256.27 202.42 26.60 547.30 310.17 76.45 947.49 552.46 71.50
Equity 507.19 507.19 0.00 507.19 507.19 0.00 507.19 408.16 24.26
PBIDTM(%) 16.86 16.04 5.11 16.82 14.65 14.83 17.22 15.48 11.25
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..